Back to top

Carlsmed initiated with a Buy at Needham

Needham analyst David Saxon initiated coverage of Carlsmed (CARL) with a Buy rating and $17 price target The firm believes the company’s personaliz...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: